$17.2
SI-BONE
Performance
Dividends
19.44%
1W
1M
YTD
1Y
3Y
18/36
Growth Score
11/36
Dividend Score
Valuation
PE Ratio
-27.43
PS Ratio
4.15
RSI
-
0
PEG Ratio
-0.02
3
PRG Ratio
0.14
PDG Ratio
0
Growth
331%120%018%017%
29%29%15%29%
2023
2024
2025*
2026*
3
Revenue
Revenue
*Analyst estimated growth
Fundamentals
3
Rule of 40
97.11%
3
Gross Margin
79.25%
3
Current Ratio
8.53
Return on Assets
-11.68%
Return on Equity
-16%
Return on inv. Capital
-15.01%
Institutional Holder
43.193.972045.352.328
1252159
Shares
Holders
Financials
Yealy
Quarterly
Revenue 2024 167.18M
2018
2019
2020
2021
2022
2023
2024
6
Net Income 2024 -30.91M
2018
2019
2020
2021
2022
2023
2024
6
Gross Profit 2024 132.12M
2018
2019
2020
2021
2022
2023
2024
6
Events
SIBN
SI-BONE
in 477 days
after market close
Earnings per Share is expected with - and revenue with - .
SIBN
SI-BONE
in 379 days
after market close
Earnings per Share is expected with - and revenue with - .
SIBN
SI-BONE
in 288 days
after market close
Earnings per Share is expected with - and revenue with - .
About
Sector/Industry
Healthcare
Medical - Devices
IPO Date
17.10.2018
MaketCap
732.97M
Country
US
CEO
Laura A. Francis MBA
Description
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Updated 13.07.2025